bBHC Stem Cell Treatment & Research Institute discovered the newly Elicited pluripotent Stem Cell without side effects which is called nEPS.
We've been differentiated nEPS into endoderm,mesoderm and ectoderm. Our goal is overcome to incurable diseas using in nEPS.
Company Details
- Employees
- 13
- Founded
- -
- Address
- 서울특별시 용산구 유엔빌리지길 72, 서울,seoul 04420,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- stcstri.com
- Keywords
- Aksia.
- HQ
- 서울, Seoul
Bbhc-Stri Questions
Bbhc-Stri's website is stcstri.com
Bbhc-Stri's LinkedIn profile is https://kr.linkedin.com/company/stri
Bbhc-Stri has
13 employees.
View email and phone details for 13
employees at Bbhc-Stri.
Bbhc-Stri's industry is
Biotechnology Research
Bbhc-Stri's top competitors are
Aksia,
Blackrock,
Ing,
Cpp Investments | Investissements Rpc,
Avanda Investment Management,
Fullerton Fund Management,
Albourne,
Gcm Grosvenor.
Bbhc-Stri's categories are Biotechnology Research
Bbhc-Stri's founding year is 1989
